Skip to main content
Erschienen in: International Urology and Nephrology 7/2016

27.02.2016 | Nephrology - Original Paper

Urine and serum ghrelin, sCD80 and sCTLA-4 levels in doxorubicin-induced experimental nephrotic syndrome

verfasst von: Duygu Ozkorucu, Nuran Cetin, Nadide Melike Sav, Bilal Yildiz

Erschienen in: International Urology and Nephrology | Ausgabe 7/2016

Einloggen, um Zugang zu erhalten

Abstract

Background

Nephrotic syndrome (NS) is an immune-mediated disorder associated with hyperlipidemia. NS has been proposed to be mediated through CD80-related T cell immune response, which could be blocked using soluble cytotoxic T lymphocyte-associated s(CTLA)-4. Although ghrelin is a hormone-modulating lipid metabolism and suppressing immune system, the precise role of ghrelin in NS is not well established.

Methods

We evaluated the levels of ghrelin, soluble CD80 (sCD80) and sCTLA4 in serum and urine in doxorubicin-induced NS in rats. We also investigated the relation between their levels and the levels of serum total cholesterol (TC), triglyceride, albumin and urine protein.

Results

While urinary ghrelin levels were significantly lower in the nephrotic rats compared to the control group, serum ghrelin levels were comparable in the nephrotic and control rats. In contrast, serum and urinary sCD80 and sCTLA4 levels were higher in the nephrotic rats than the controls. The urinary ghrelin levels were negatively correlated with the levels of serum triglyceride, TC and urine protein, sCD80 and sCTLA4. The urine sCD80 levels were positively correlated with the TC, urine protein and urine sCTLA4 levels, and negatively correlated with the serum albumin. The urine sCTLA4 levels were positively correlated with the TC and urine protein levels and negatively correlated with the serum albumin levels. In regression analysis, the urine ghrelin levels significantly relate to urine sCD80 levels. Besides, hyperlipidemia in NS did not appear to be related to serum ghrelin levels.

Conclusion

Low urine ghrelin levels might be relevant to pathogenesis of doxorubicin-induced NS. The reduction in urine ghrelin levels might also be associated with increased levels of urine sCTLA4 and sCD80 which reflect proteinuria.
Literatur
1.
Zurück zum Zitat Hosoda H, Kojima M, Kangawa K (2006) Biological, physiological, and pharmacological aspects of ghrelin. J Pharmacol Sci 100:398–410CrossRefPubMed Hosoda H, Kojima M, Kangawa K (2006) Biological, physiological, and pharmacological aspects of ghrelin. J Pharmacol Sci 100:398–410CrossRefPubMed
2.
Zurück zum Zitat Verhulst PJ, Depoortere I (2012) Ghrelin’s second life: from appetite stimulator to glucose regulator. World J Gastroenterol 18:3183–3195PubMedPubMedCentral Verhulst PJ, Depoortere I (2012) Ghrelin’s second life: from appetite stimulator to glucose regulator. World J Gastroenterol 18:3183–3195PubMedPubMedCentral
3.
4.
Zurück zum Zitat Lim CT, Kola B, Korbonits M (2011) The ghrelin/GOAT/GHS-R system and energy metabolism. Rev Endocr Metab Disord 12:173–186CrossRefPubMed Lim CT, Kola B, Korbonits M (2011) The ghrelin/GOAT/GHS-R system and energy metabolism. Rev Endocr Metab Disord 12:173–186CrossRefPubMed
5.
Zurück zum Zitat Nogueiras R, Wiedmer P, Perez-Tilve D, Veyrat-Durebex C, Keogh JM, Sutton GM, Pfluger PT, Castaneda TR, Neschen S, Hofmann SM et al (2007) The central melanocortin system directly controls peripheral lipid metabolism. J Clin Investig 117:3475–3488CrossRefPubMedPubMedCentral Nogueiras R, Wiedmer P, Perez-Tilve D, Veyrat-Durebex C, Keogh JM, Sutton GM, Pfluger PT, Castaneda TR, Neschen S, Hofmann SM et al (2007) The central melanocortin system directly controls peripheral lipid metabolism. J Clin Investig 117:3475–3488CrossRefPubMedPubMedCentral
6.
Zurück zum Zitat Andrews ZB, Erion DM, Beiler R, Choi CS, Shulman GI, Horvath TL (2010) Uncoupling protein-2 decreases the lipogenic actions of ghrelin. Endocrinology 151:2078–2086CrossRefPubMedPubMedCentral Andrews ZB, Erion DM, Beiler R, Choi CS, Shulman GI, Horvath TL (2010) Uncoupling protein-2 decreases the lipogenic actions of ghrelin. Endocrinology 151:2078–2086CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Perez-Tilve D, Hofmann SM, Basford J, Nogueiras R, Pfluger PT, Patterson JT, Grant E, Wilson-Perez HE, Granholm NA, Arnold M, Trevaskis JL, Butler AA, Davidson WS, Woods SC, Benoit SC, Sleeman MW, DiMarchi RD, Hui DY, Tschöp MH (2010) Melanocortin signaling in the CNS directly regulates circulating cholesterol. Nat Neurosci 13:877–882CrossRefPubMedPubMedCentral Perez-Tilve D, Hofmann SM, Basford J, Nogueiras R, Pfluger PT, Patterson JT, Grant E, Wilson-Perez HE, Granholm NA, Arnold M, Trevaskis JL, Butler AA, Davidson WS, Woods SC, Benoit SC, Sleeman MW, DiMarchi RD, Hui DY, Tschöp MH (2010) Melanocortin signaling in the CNS directly regulates circulating cholesterol. Nat Neurosci 13:877–882CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat Cheyuo C, Jacob A, Wang P (2012) Ghrelin-mediated sympathoinhibition and suppression of inflammation in sepsis. Am J Physiol Endocrinol Metab 1(302):E265–E272CrossRef Cheyuo C, Jacob A, Wang P (2012) Ghrelin-mediated sympathoinhibition and suppression of inflammation in sepsis. Am J Physiol Endocrinol Metab 1(302):E265–E272CrossRef
9.
Zurück zum Zitat Granado M, Priego T, Martin AI, Villanua MA, Lopez-Calderon A (2005) Anti-inflammatory effect of the ghrelin agonist growth hormone-releasing peptide-2 (GHRP-2) in arthritic rats. Am J Physiol Endocrinol Metab 288:486–492CrossRef Granado M, Priego T, Martin AI, Villanua MA, Lopez-Calderon A (2005) Anti-inflammatory effect of the ghrelin agonist growth hormone-releasing peptide-2 (GHRP-2) in arthritic rats. Am J Physiol Endocrinol Metab 288:486–492CrossRef
10.
Zurück zum Zitat Souza-Moreira L, Campos-Salinas J, Caro M, Gonzalez-Rey E (2011) Neuropeptides as pleiotropic modulators of the immune response. Neuroendocrinology 94:89–100CrossRefPubMed Souza-Moreira L, Campos-Salinas J, Caro M, Gonzalez-Rey E (2011) Neuropeptides as pleiotropic modulators of the immune response. Neuroendocrinology 94:89–100CrossRefPubMed
11.
Zurück zum Zitat Rajan D, Wu R, Shah KG, Jacob A, Coppa GF, Wang P (2012) Human ghrelin protects animals from renal ischemia-reperfusion injury through the vagus nerve. Surgery 151:37–47CrossRefPubMed Rajan D, Wu R, Shah KG, Jacob A, Coppa GF, Wang P (2012) Human ghrelin protects animals from renal ischemia-reperfusion injury through the vagus nerve. Surgery 151:37–47CrossRefPubMed
12.
Zurück zum Zitat Khowailed A, Younan SM, Ashour H, Kamel AE, Sharawy N (2015) Effects of ghrelin on sepsis induced acute kidney injury: one step forward. Clin Exp Nephrol 19:419–426CrossRefPubMed Khowailed A, Younan SM, Ashour H, Kamel AE, Sharawy N (2015) Effects of ghrelin on sepsis induced acute kidney injury: one step forward. Clin Exp Nephrol 19:419–426CrossRefPubMed
13.
Zurück zum Zitat Baatar D, Patel K, Taub DD (2011) The effects of ghrelin on inflammation and the immune system. Mol Cell Endocrinol 20(340):44–58CrossRef Baatar D, Patel K, Taub DD (2011) The effects of ghrelin on inflammation and the immune system. Mol Cell Endocrinol 20(340):44–58CrossRef
14.
Zurück zum Zitat Elie V, Fakhoury M, Deschênes G, Jacqz-Aigrain E (2012) Physiopathology of idiopathic nephrotic syndrome: lessons from glucocorticoids and epigenetic perspectives. Pediatr Nephrol 27:1249–1256CrossRefPubMed Elie V, Fakhoury M, Deschênes G, Jacqz-Aigrain E (2012) Physiopathology of idiopathic nephrotic syndrome: lessons from glucocorticoids and epigenetic perspectives. Pediatr Nephrol 27:1249–1256CrossRefPubMed
15.
Zurück zum Zitat Shimada M, Araya C, Rivard C, Ishimoto T, Johnson RJ, Garin EH (2011) Minimal change disease: a“two-hit”podocyte immune disorder? Pediatr Nephrol 26:645–649CrossRefPubMed Shimada M, Araya C, Rivard C, Ishimoto T, Johnson RJ, Garin EH (2011) Minimal change disease: a“two-hit”podocyte immune disorder? Pediatr Nephrol 26:645–649CrossRefPubMed
16.
Zurück zum Zitat Cara-Fuentes G, Wasserfall CH, Wang H, Johnson RJ, Garin EH (2014) Minimal change disease: a dysregulation of the podocyte CD80-CTLA-4 axis? Pediatr Nephrol 29:2333–2340CrossRefPubMedPubMedCentral Cara-Fuentes G, Wasserfall CH, Wang H, Johnson RJ, Garin EH (2014) Minimal change disease: a dysregulation of the podocyte CD80-CTLA-4 axis? Pediatr Nephrol 29:2333–2340CrossRefPubMedPubMedCentral
17.
Zurück zum Zitat Ling C, Liu X, Shen Y, Chen Z, Fan J, Jiang Y, Meng Q (2015) Urinary CD80 levels as a diagnostic biomarker of minimal change disease. Pediatr Nephrol 30:309–316CrossRefPubMed Ling C, Liu X, Shen Y, Chen Z, Fan J, Jiang Y, Meng Q (2015) Urinary CD80 levels as a diagnostic biomarker of minimal change disease. Pediatr Nephrol 30:309–316CrossRefPubMed
18.
Zurück zum Zitat Bour-Jordan H, Esensten JH, Martinez-Llordella M, Penaranda C, Stumpf M, Bluestone JA (2011) Intrinsic and extrinsic control of peripheral T-cell tolerance by costimulatory molecules of the CD28/ B7 family. Immunol Rev 241:180–205CrossRefPubMedPubMedCentral Bour-Jordan H, Esensten JH, Martinez-Llordella M, Penaranda C, Stumpf M, Bluestone JA (2011) Intrinsic and extrinsic control of peripheral T-cell tolerance by costimulatory molecules of the CD28/ B7 family. Immunol Rev 241:180–205CrossRefPubMedPubMedCentral
19.
Zurück zum Zitat Ishimoto T, Shimada M, Araya CE, Huskey J, Garin EH, Johnson RJ (2011) Minimal change disease: a CD80 podocytopathy? Semin Nephrol 31:320–325CrossRefPubMed Ishimoto T, Shimada M, Araya CE, Huskey J, Garin EH, Johnson RJ (2011) Minimal change disease: a CD80 podocytopathy? Semin Nephrol 31:320–325CrossRefPubMed
20.
Zurück zum Zitat Lee VW, Harris DC (2011) Adriamycin nephropathy: a model of focal segmental glomerulosclerosis. Nephrology 16:30–38CrossRefPubMed Lee VW, Harris DC (2011) Adriamycin nephropathy: a model of focal segmental glomerulosclerosis. Nephrology 16:30–38CrossRefPubMed
21.
Zurück zum Zitat Ebal E, Cavalié H, Michaux O, Lac G (2007) Effect of a lipid-enriched diet on body composition and some regulatory hormones of food intake in growing rats. Ann Endocrinol (Paris) 68:366–371CrossRef Ebal E, Cavalié H, Michaux O, Lac G (2007) Effect of a lipid-enriched diet on body composition and some regulatory hormones of food intake in growing rats. Ann Endocrinol (Paris) 68:366–371CrossRef
22.
Zurück zum Zitat Zhang Z, Li Q, Liu F, Sun Y, Zhang J (2010) Prevention of diet-induced obesity by safflower oil: insights at the levels of PPARalpha, orexin, and ghrelin gene expression of adipocytes in mice. Acta Biochim Biophys Sin (Shanghai) 15(42):202–208CrossRef Zhang Z, Li Q, Liu F, Sun Y, Zhang J (2010) Prevention of diet-induced obesity by safflower oil: insights at the levels of PPARalpha, orexin, and ghrelin gene expression of adipocytes in mice. Acta Biochim Biophys Sin (Shanghai) 15(42):202–208CrossRef
23.
Zurück zum Zitat Aydin S, Sahin I, Ozkan Y, Dag E, Gunay A, Guzel SP, Catak Z, Ozercan MR (2012) Examination of the tissue ghrelin expression of rats with diet-induced obesity using radioimmunoassay and immunohistochemical methods. Mol Cell Biochem 365:165–173CrossRefPubMed Aydin S, Sahin I, Ozkan Y, Dag E, Gunay A, Guzel SP, Catak Z, Ozercan MR (2012) Examination of the tissue ghrelin expression of rats with diet-induced obesity using radioimmunoassay and immunohistochemical methods. Mol Cell Biochem 365:165–173CrossRefPubMed
24.
Zurück zum Zitat Saverino Daniele, Simone Rita, Bagnasco Marcello, Pesce Giampaola (2010) The soluble CTLA-4 receptor and its role in autoimmune diseases: an update. Autoimmun Highlights 1:73–81CrossRef Saverino Daniele, Simone Rita, Bagnasco Marcello, Pesce Giampaola (2010) The soluble CTLA-4 receptor and its role in autoimmune diseases: an update. Autoimmun Highlights 1:73–81CrossRef
25.
Zurück zum Zitat Taub DD (2008) Novel connections between the neuroendocrine and immune systems: the ghrelin immunoregulatory network. Vitam Hormon 77:325–346CrossRef Taub DD (2008) Novel connections between the neuroendocrine and immune systems: the ghrelin immunoregulatory network. Vitam Hormon 77:325–346CrossRef
26.
Zurück zum Zitat Cheyuo C, Wu R, Zhou M, Jacob A, Coppa G, Wang P (2011) Ghrelin suppresses inflammation and neuronal nitric oxide synthase in focal cerebral ischemia via the vagus nerve. Shock 35:258–265CrossRefPubMed Cheyuo C, Wu R, Zhou M, Jacob A, Coppa G, Wang P (2011) Ghrelin suppresses inflammation and neuronal nitric oxide synthase in focal cerebral ischemia via the vagus nerve. Shock 35:258–265CrossRefPubMed
27.
Zurück zum Zitat Taub DD, Longo DL (2005) Insights into thymic aging and regeneration. Immunol Rev 205:72–93CrossRefPubMed Taub DD, Longo DL (2005) Insights into thymic aging and regeneration. Immunol Rev 205:72–93CrossRefPubMed
28.
Zurück zum Zitat Garin EH, Diaz LN, Mu W, Wasserfall C, Araya C, Segal M, Johnson RJ (2009) Urinary CD80 excretion increases in idiopathic minimal-change disease. J Am Soc Nephrol 20:260–266CrossRefPubMedPubMedCentral Garin EH, Diaz LN, Mu W, Wasserfall C, Araya C, Segal M, Johnson RJ (2009) Urinary CD80 excretion increases in idiopathic minimal-change disease. J Am Soc Nephrol 20:260–266CrossRefPubMedPubMedCentral
29.
Zurück zum Zitat Sakthivel P, Wermeling F, Elmgren A, Hulthe J, Kakoulidou M, Lefvert AK, Lind L (2010) Circulating soluble CTLA-4 is related to inflammatory markers in the 70 year old population. Scand J Clin Lab Investig 70:237–243CrossRef Sakthivel P, Wermeling F, Elmgren A, Hulthe J, Kakoulidou M, Lefvert AK, Lind L (2010) Circulating soluble CTLA-4 is related to inflammatory markers in the 70 year old population. Scand J Clin Lab Investig 70:237–243CrossRef
30.
Zurück zum Zitat Li JY, Yong TY, Michael MZ, Gleadle JM (2010) Review: the role of microRNAs in kidney disease. Nephrology (Carlton) 15:599–608CrossRef Li JY, Yong TY, Michael MZ, Gleadle JM (2010) Review: the role of microRNAs in kidney disease. Nephrology (Carlton) 15:599–608CrossRef
31.
Zurück zum Zitat Luo Y, Wang C, Chen X, Zhong T, Cai X, Chen S, Shi Y, Hu J, Guan X, Xia Z, Wang J, Zen K, Zhang CY, Zhang C (2013) Increased serum and urinary microRNAs in children with idiopathic nephrotic syndrome. Clin Chem 59:658–666CrossRefPubMed Luo Y, Wang C, Chen X, Zhong T, Cai X, Chen S, Shi Y, Hu J, Guan X, Xia Z, Wang J, Zen K, Zhang CY, Zhang C (2013) Increased serum and urinary microRNAs in children with idiopathic nephrotic syndrome. Clin Chem 59:658–666CrossRefPubMed
32.
Zurück zum Zitat Khella HW, Bakhet M, Lichner Z, Romaschin AD, Jewett MA, Yousef GM (2013) MicroRNAs in kidney disease: an emerging understanding. Am J Kidney Dis 61:798–808CrossRefPubMed Khella HW, Bakhet M, Lichner Z, Romaschin AD, Jewett MA, Yousef GM (2013) MicroRNAs in kidney disease: an emerging understanding. Am J Kidney Dis 61:798–808CrossRefPubMed
Metadaten
Titel
Urine and serum ghrelin, sCD80 and sCTLA-4 levels in doxorubicin-induced experimental nephrotic syndrome
verfasst von
Duygu Ozkorucu
Nuran Cetin
Nadide Melike Sav
Bilal Yildiz
Publikationsdatum
27.02.2016
Verlag
Springer Netherlands
Erschienen in
International Urology and Nephrology / Ausgabe 7/2016
Print ISSN: 0301-1623
Elektronische ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-016-1249-4

Weitere Artikel der Ausgabe 7/2016

International Urology and Nephrology 7/2016 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.